Geographic Atrophy Treatments

Geographic Atrophy is a long game, and so is treatment. In this video, Dr. Mona Camacci, vitreoretinal surgeon at Retina Consultants of South Carolina, shares the conversation she has with every GA patient: Your vision today is likely the best it will be. These treatments are not designed to improve vision, they are designed to slow progression. Early studies showed about a 20% slowing of GA growth. With longer-term data, we’re now seeing closer to 30–40% slowing in patients who stay on therapy. And that additional time with functional vision can make a meaningful difference in daily life. Dr. Camacci also highlights why imaging matters. Fundus photos, fundus autofluorescence, and OCT allow us to track lesion growth over time. On autofluorescence, GA appears dark and enlargement becomes clearly visible when compared to baseline images. Early referral. Baseline imaging. Timely intervention. These decisions work best when retina specialists and referring doctors approach them together. Disclosures: Dr. Camacci has financial disclosures with Astellas Pharma This GA series is an editorially independent series with support from Astellas